Clinical Trial Update: Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction

View source ↗

Summary

This clinical trial update reports the completion of a safety study evaluating Hearticellgram-AMI in patients with acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Hearticellgram-AMI

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Acute Myocardial Infarction | Status: COMPLETED